I have to assume medac is a dud. B/O seems unworthy given revenue history, I mean why should U.S. be that different from Germany other than 4 times larger. Finance people have been a leading indicator perhaps of stock value ever since 2013 when Simpson took over. Imo finance people will not become positive thinkers at this point, so where this can trade is just the reverse of icing on a cake
After they win this case the new investor will invest big $$ amount to launch back on Nasdaq and get them file NDA and FDA approval, they may need to do an RS but it will be the best RS the long term investors will ever face!